Studies have shown that urokinase plasminogen activator (uPA) and urokinase-type plasminogen activator receptor (uPAR) are involved in the pathogenesis of COVID-19 and contribute to the development of PF through single-cell RNA-seq and immunohistochemical analysis. This evidence concerns the gene PLAU and pemphigus foliaceus.